Royalty Pharma plc·4

May 14, 5:02 PM ET

Legorreta Pablo G. 4

4 · Royalty Pharma plc · Filed May 14, 2025

Insider Transaction Report

Form 4
Period: 2025-05-12
Legorreta Pablo G.
DirectorCEO, Chairman of the Board
Transactions
  • Gift

    Class B Ordinary Shares

    2025-05-12867,1800 total(indirect: By Spouse)
    Exercise: $0.00Class A Ordinary Shares (867,180 underlying)
  • Gift

    Class B Ordinary Shares

    2025-05-12+867,1800 total
    Exercise: $0.00Class A Ordinary Shares (867,180 underlying)
Holdings
  • Class B Ordinary Shares

    (indirect: By LLC)
    Exercise: $0.00Class A Ordinary Shares (9,700,000 underlying)
    9,700,000
Footnotes (3)
  • [F1]Reflects an exempt gift for no consideration of Class B ordinary shares ("Class B Shares") of Royalty Pharma Holdings Ltd ("RPH") from the reporting person's spouse to the reporting person. The Class B Shares held by the reporting person's spouse were originally received in an exempt pro rata distribution pursuant to Rule 16a-9(a).
  • [F2]Each Class B Share may be converted at any time into an equivalent number of Class A ordinary shares of the Issuer on a one-for-one basis (at which time, a corresponding number of Class B ordinary shares will also be forfeited and redesignated on a one-for-one basis), and there is no expiration date for such conversion.
  • [F3]Reflects the exempt transfer pursuant to Rule 16a-13 of Class B Shares from the reporting person and the GST-Exempt Legorreta 2020 Family Trust to PL RPH AIV, LLC, which is solely beneficially owned by the reporting person. The Class B Shares transferred by the reporting person and the GST-Exempt Legorreta 2020 Family Trust were originally received in exempt pro rata distributions pursuant to Rule 16a-9(a) and the gift transaction reported in this filing.

Documents

1 file
  • 4
    wk-form4_1747256539.xmlPrimary

    FORM 4